Sun Pharma announces USFDA OK for Generic Strattera capsules

Businesswire India
Posted: Friday, Nov 27, 2009 at 1053 hrs IST
Updated: Friday, Nov 27, 2009 at 1053 hrs IST

Font Size

Feedback

Discuss

Discount UK Shopping

Antony Waste Handling Cell Private Limited wins th...Shalina Laboratories celebrates the Silver Jubilee...Global Network of Universities launch program to t...VCherish Media launches VCherish.com

Mumbai: Sun Pharma announced that the USFDA has granted a tentative approval for an Abbreviated New Drug Application (ANDA) for generic Strattera®, atomoxetine hydrochloride capsules.

These atomoxetine hydrochloride capsules, therapeutically equivalent to Strattera® capsules from Eli Lilly, are available in seven strengths viz. 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg and 100 mg. Atomoxetine hydrochloride capsules have annual sales of approximately USD 500 million in the US.

Strattera® capsules are indicated for the treatment of attention deficit hyperactivity disorder.

Strattera® is a registered trademark of Eli Lilly and Company.

More from Business Wire

Antony Waste Handling Cell Private Limited wins the 2009 Market Leadership Award Shalina Laboratories celebrates the Silver Jubilee of their operations in India Global Network of Universities launch program to train leaders in sustainable development practice Brickwork Ratings assigns ‘BWR BB’ rating to Akarsh Residence Pvt Ltd’s proposed secured NCD issue of Rs 100 cr PM calls for a united global action to reach consensus on climate change at the 10th Delhi Sustainable Development Summit Tenth Delhi Sustainable Development Summit calls for a global integrated action to tackle climate PlaySpan hosts second Annual Monetization 2.0 Forum Gulf Oil and CarWale flag off All-India Drive

Discuss this story on expressindia forums

Post Comments

Comments: (Limit 3,000 characters)

Name		Message
Email ID
Subject

TERMS OF USE:
The views, opinions and comments posted are your, and are not endorsed by this website. You shall be solely responsible for the comment posted here. The website reserves the right to delete, reject, or otherwise remove any views, opinions and comments posted or part thereof. You shall ensure that the comment is not inflammatory, abusive, derogatory, defamatory &/or obscene, or contain pornographic matter and/or does not constitute hate mail, or violate privacy of any person (s) or breach confidentiality or otherwise is illegal, immoral or contrary to public policy. Nor should it contain anything infringing copyright &/or intellectual property rights of any person(s).

I agree to the terms of use.

Latest News

Print Edition

Events

Sun Pharma announces USFDA OK for Generic Strattera capsules

Post Comments